Skip to main content
Top
Published in: Journal of Gastroenterology 9/2017

01-09-2017 | Original Article—Liver, Pancreas, and Biliary Tract

Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma

Authors: An-Ye Zhang, Ching-Lung Lai, Fung-Yu Huang, Wai-Kay Seto, James Fung, Danny Ka-Ho Wong, Man-Fung Yuen

Published in: Journal of Gastroenterology | Issue 9/2017

Login to get access

Abstract

Background

The association between the evolution of hepatitis B virus (HBV) quasispecies and the development of hepatocellular carcinoma (HCC) is unknown.

Methods

We used deep sequencing to examine the dynamics of HBV quasispecies and their relationship to HCC development. Thirty-two chronic hepatitis B (CHB) patients with HCC (HCC group) and 32 matched CHB patients without HCC (controls) were recruited. Fourteen patients from each group had serial sera available up to 9 years before the time of the present study. Deep sequencing of the HBV pre-S regions was performed. HBV quasispecies complexity, diversity, and intrapatient prevalence of pre-S deletions/mutations were analyzed.

Results

Compared with control patients, HCC patients had a significant greater quasispecies complexity (p = 0.04 at the nucleotide level), greater diversity (p = 0.004 and 0.009 at the nucleotide level and the amino acid level respectively), and a trend of greater complexity at the amino acid level (p = 0.065). HCC patients had a higher intrapatient prevalence of pre-S deletions and point mutations (at codons 4, 27, and 167) compared with the control patients (all p < 0.05). Longitudinal observation in the sera of 14 HCC patients showed that quasispecies complexity (p = 0.027 and 0.024 at the nucleotide level and the amino acid level respectively) and diversity (p = 0.035 and 0.031 at the nucleotide level and the amino acid level respectively) increased as the disease progressed to HCC.

Conclusions

Increased HBV quasispecies complexity and diversity in the pre-S region, probably reflecting enhanced virus–host interplay, was associated with disease progression from CHB to HCC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.CrossRefPubMed Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol. 2008;48:335–52.CrossRefPubMed
2.
4.
go back to reference Chevaliez S, Rodriguez C, Pawlotsky JM. New virologic tools for management of chronic hepatitis B and C. Gastroenterology. 2012;142(1303–1313):e1. Chevaliez S, Rodriguez C, Pawlotsky JM. New virologic tools for management of chronic hepatitis B and C. Gastroenterology. 2012;142(1303–1313):e1.
5.
go back to reference Ciftci S, Keskin F, Cakiris A, et al. Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method. Diagn Microbiol Infect Dis. 2014;79:25–30.CrossRefPubMed Ciftci S, Keskin F, Cakiris A, et al. Analysis of potential antiviral resistance mutation profiles within the HBV reverse transcriptase in untreated chronic hepatitis B patients using an ultra-deep pyrosequencing method. Diagn Microbiol Infect Dis. 2014;79:25–30.CrossRefPubMed
6.
go back to reference Ko SY, Oh HB, Park CW, et al. Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing. Clin Microbiol Infect. 2012;18:E404–11.CrossRefPubMed Ko SY, Oh HB, Park CW, et al. Analysis of hepatitis B virus drug-resistant mutant haplotypes by ultra-deep pyrosequencing. Clin Microbiol Infect. 2012;18:E404–11.CrossRefPubMed
7.
go back to reference Rodriguez C, Chevaliez S, Bensadoun P, et al. Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing. Hepatology. 2013;58:890–901.CrossRefPubMed Rodriguez C, Chevaliez S, Bensadoun P, et al. Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing. Hepatology. 2013;58:890–901.CrossRefPubMed
8.
go back to reference Lin CL, Liu CH, Chen W, et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:1098–103.CrossRefPubMed Lin CL, Liu CH, Chen W, et al. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. J Gastroenterol Hepatol. 2007;22:1098–103.CrossRefPubMed
9.
go back to reference Yeung P, Wong DKH, Lai CL, et al. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J Infect Dis. 2011;203:646–54.CrossRefPubMedPubMedCentral Yeung P, Wong DKH, Lai CL, et al. Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. J Infect Dis. 2011;203:646–54.CrossRefPubMedPubMedCentral
10.
go back to reference Zhang AY, Lai CL, Huang FY, et al. Evolutionary changes of hepatitis B virus pre-S mutations prior to development of hepatocellular carcinoma. PLoS One. 2015;10:e0139478.CrossRefPubMedPubMedCentral Zhang AY, Lai CL, Huang FY, et al. Evolutionary changes of hepatitis B virus pre-S mutations prior to development of hepatocellular carcinoma. PLoS One. 2015;10:e0139478.CrossRefPubMedPubMedCentral
11.
go back to reference Kozich JJ, Westcott SL, Baxter NT, et al. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79:5112–20.CrossRefPubMedPubMedCentral Kozich JJ, Westcott SL, Baxter NT, et al. Development of a dual-index sequencing strategy and curation pipeline for analyzing amplicon sequence data on the MiSeq Illumina sequencing platform. Appl Environ Microbiol. 2013;79:5112–20.CrossRefPubMedPubMedCentral
12.
go back to reference Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537–41.CrossRefPubMedPubMedCentral Schloss PD, Westcott SL, Ryabin T, et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75:7537–41.CrossRefPubMedPubMedCentral
13.
go back to reference Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.CrossRefPubMedPubMedCentral Tamura K, Peterson D, Peterson N, et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011;28:2731–9.CrossRefPubMedPubMedCentral
14.
go back to reference Lim SG, Cheng Y, Guindon S, et al. Viral quasi-species evolution during hepatitis be antigen seroconversion. Gastroenterology. 2007;133:951–8.CrossRefPubMed Lim SG, Cheng Y, Guindon S, et al. Viral quasi-species evolution during hepatitis be antigen seroconversion. Gastroenterology. 2007;133:951–8.CrossRefPubMed
15.
go back to reference Wu S, Imazeki F, Kurbanov F, et al. Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. J Hepatol. 2011;54:19–25.CrossRefPubMed Wu S, Imazeki F, Kurbanov F, et al. Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. J Hepatol. 2011;54:19–25.CrossRefPubMed
16.
go back to reference Abe K, Thung SN, Wu HC, et al. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci. 2009;100:2249–54.CrossRefPubMed Abe K, Thung SN, Wu HC, et al. Pre-S2 deletion mutants of hepatitis B virus could have an important role in hepatocarcinogenesis in Asian children. Cancer Sci. 2009;100:2249–54.CrossRefPubMed
17.
go back to reference Hsieh YH, Su IJ, Wang HC, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004;25:2023–32.CrossRefPubMed Hsieh YH, Su IJ, Wang HC, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis. 2004;25:2023–32.CrossRefPubMed
18.
go back to reference Yin J, Xie J, Zhang H, et al. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol. 2010;45:1063–71.CrossRefPubMed Yin J, Xie J, Zhang H, et al. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma. J Gastroenterol. 2010;45:1063–71.CrossRefPubMed
19.
go back to reference Chen CH, Changchien CS, Lee CM, et al. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis. 2008;198:1634–42.CrossRefPubMed Chen CH, Changchien CS, Lee CM, et al. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study. J Infect Dis. 2008;198:1634–42.CrossRefPubMed
20.
go back to reference Gallina A, De Koning A, Rossi F, et al. Intracellular retention of hepatitis B virus surface protein mutants devoid of amino-terminal pre-S1 sequences. J Gen Virol. 1994;75(Pt 2):449–55.CrossRefPubMed Gallina A, De Koning A, Rossi F, et al. Intracellular retention of hepatitis B virus surface protein mutants devoid of amino-terminal pre-S1 sequences. J Gen Virol. 1994;75(Pt 2):449–55.CrossRefPubMed
21.
go back to reference Pollicino T, Amaddeo G, Restuccia A, et al. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology. 2012;56:434–43.CrossRefPubMed Pollicino T, Amaddeo G, Restuccia A, et al. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. Hepatology. 2012;56:434–43.CrossRefPubMed
22.
go back to reference Cao L, Wu C, Shi H, et al. Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses. J Virol. 2014;88:8656–66.CrossRefPubMedPubMedCentral Cao L, Wu C, Shi H, et al. Coexistence of hepatitis B virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses. J Virol. 2014;88:8656–66.CrossRefPubMedPubMedCentral
23.
go back to reference Van den Hoecke S, Verhelst J, Vuylsteke M, et al. Analysis of the genetic diversity of influenza a viruses using next-generation DNA sequencing. BMC Genomics. 2015;16:79.CrossRefPubMedPubMedCentral Van den Hoecke S, Verhelst J, Vuylsteke M, et al. Analysis of the genetic diversity of influenza a viruses using next-generation DNA sequencing. BMC Genomics. 2015;16:79.CrossRefPubMedPubMedCentral
24.
go back to reference Quail MA, Smith M, Coupland P, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 2012;13:341.CrossRefPubMedPubMedCentral Quail MA, Smith M, Coupland P, et al. A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics. 2012;13:341.CrossRefPubMedPubMedCentral
Metadata
Title
Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma
Authors
An-Ye Zhang
Ching-Lung Lai
Fung-Yu Huang
Wai-Kay Seto
James Fung
Danny Ka-Ho Wong
Man-Fung Yuen
Publication date
01-09-2017
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 9/2017
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-017-1334-1

Other articles of this Issue 9/2017

Journal of Gastroenterology 9/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.